| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V88002 | c-Fms-IN-15 | c-Fms-IN-15 (compound 8g) is a potent inhibitor of FMS kinase with IC50 of 563 nM. | |
|
V88001 | CSF1R-IN-25 | 2070864-23-0 | CSF1R-IN-25 (compound 36) is an orally available inhibitor of CSF1R. |
|
V23228 | KI-20227 | 623142-96-1 | KI-20227 is a potent and orally bioavailable inhibitor of c-Fms tyrosine kinase (M-CSFR, CSF1R) (IC50 are 2, 12, 217 and 451 nM for c-Fms, VEGFR-2, PDGFRβ and c-Kit respectively). |
|
V69285 | PLX647 dihydrochloride | 1779796-38-1 | PLX647 di-HCl is an orally bioactive, specific dual kinase inhibitor of FMS and KIT with IC50 of 28 and 16 nM, respectively. |
|
V87999 | PXB17 | PXB17 can inhibit CSF1R (IC50 = 1.7 nM) by blocking the activation of PI3K/AKT/mTORC1 signaling. | |
|
V3765 | Edicotinib | 1142363-52-7 | Edicotinib (formerly known as JNJ-527; JNJ-40346527) is a novel selective and orally bioavailable inhibitor of colony-stimulating factor-1 (CSF-1) receptor kinase with anticancer activity. |
|
V14353 | Pexidartinib HCl | 2040295-03-0 | Pexidartinib HCl (formerly also know as PLX-3397 HCl) is a novel, orally bioavailable, potent multi-targeted receptor tyrosine kinase inhibitor of CSF-1R, Kit, and Flt3 with IC50 of 20 nM, 10 nM and 160 nM, respectively. |